Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sasha Smolgovsky

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|December 1, 2023
Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosisSasha Smolgovsky, Brandon Theall, Noah Wagner, et al.
Cellular Signalling|November 9, 2020
Adding insult to injury - Inflammation at the heart of cardiac fibrosisSasha Smolgovsky, Udoka Ibeh, Tatiana Peña Tamayo, et al.
The American Journal of Pathology|March 5, 2024
Deletion of MyD88 in T Cells Improves Antitumor Activity in MelanomaAbraham L Bayer, Darwing Padilla-Rolon, Sasha Smolgovsky, et al.
Frontiers in Physiology|December 20, 2021
Sialomucin CD43 Plays a Deleterious Role in the Development of Experimental Heart Failure Induced by Pressure Overload by Modulating Cardiac Inflammation and FibrosisKuljeet Kaur, Francisco E Velázquez, Marina Anastasiou, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2025
Experimental pressure overload induces a cardiac neoantigen specific humoral immune responseSasha Smolgovsky, Abraham L Bayer, Mark Aronovitz, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
T cell-derived IFNγ instructs ECM crosslinking by cardiac fibroblasts through LOXL3 in experimental cardiometabolic HFpEFRamona Emig, Zachary Robbe, Celina Kley, et al.
Circulation Research|July 26, 2023
T-Cell MyD88 Is a Novel Regulator of Cardiac Fibrosis Through Modulation of T-Cell ActivationAbraham L Bayer, Sasha Smolgovsky, Njabulo Ngwenyama, et al.
Nature Cardiovascular Research|August 28, 2024
Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunctionAbraham L Bayer, Maria A Zambrano, Sasha Smolgovsky, et al.
Scientific Reports|April 22, 2021
Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNAAnn-Sophie Walravens, Sasha Smolgovsky, Liang Li, et al.
Cardiovascular Research|June 6, 2026
STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathyAbraham L Bayer, Maria Antonia Zambrano, Ramona Emig, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Heart and Circulatory Physiology|December 1, 2023
Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosisSasha Smolgovsky, Brandon Theall, Noah Wagner, et al.
Cellular Signalling|November 9, 2020
Adding insult to injury - Inflammation at the heart of cardiac fibrosisSasha Smolgovsky, Udoka Ibeh, Tatiana Peña Tamayo, et al.
The American Journal of Pathology|March 5, 2024
Deletion of MyD88 in T Cells Improves Antitumor Activity in MelanomaAbraham L Bayer, Darwing Padilla-Rolon, Sasha Smolgovsky, et al.
Frontiers in Physiology|December 20, 2021
Sialomucin CD43 Plays a Deleterious Role in the Development of Experimental Heart Failure Induced by Pressure Overload by Modulating Cardiac Inflammation and FibrosisKuljeet Kaur, Francisco E Velázquez, Marina Anastasiou, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2025
Experimental pressure overload induces a cardiac neoantigen specific humoral immune responseSasha Smolgovsky, Abraham L Bayer, Mark Aronovitz, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
T cell-derived IFNγ instructs ECM crosslinking by cardiac fibroblasts through LOXL3 in experimental cardiometabolic HFpEFRamona Emig, Zachary Robbe, Celina Kley, et al.
Circulation Research|July 26, 2023
T-Cell MyD88 Is a Novel Regulator of Cardiac Fibrosis Through Modulation of T-Cell ActivationAbraham L Bayer, Sasha Smolgovsky, Njabulo Ngwenyama, et al.
Nature Cardiovascular Research|August 28, 2024
Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunctionAbraham L Bayer, Maria A Zambrano, Sasha Smolgovsky, et al.
Scientific Reports|April 22, 2021
Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNAAnn-Sophie Walravens, Sasha Smolgovsky, Liang Li, et al.
Cardiovascular Research|June 6, 2026
STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathyAbraham L Bayer, Maria Antonia Zambrano, Ramona Emig, et al.
Pageof 2